Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
PPLPHARMA
PPLPHARMA
190.85-4.1 (-2.12%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

28.9 / 100

Value Score

27.8 / 100

Price Momentum Score

83.3 / 100

QVM Score

39.5 / 100

Key Metrics

Market Cap
25322.80
P/E (TTM)
-
P/B
3.10
P/S (TTM)
2.75
EV/EBITDA
29.57
CAPE (5Y)
-
ROE (TTM)
-4.00
ROCE (TTM)
1.87
ROA (TTM)
-1.94
Avg 3Y ROE
-0.87
Earnings 3Y CAGR
-17.86
Sales 3Y CAGR
7.80
Sales 5Y CAGR
24.72
Debt/Equity
0.70
Consensus TP
232.50
Strong Buy %
60.00
Promoter Holding
34.80
Pledged %
0.00

Share Price

Track Piramal Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -3.42 %
Low
185.0
High
201.7
1 Month returns: -9.44 %
Low
185.0
High
214.9
1 Year returns: -6.28 %
Low
132.3
High
231.9
3 Year CAGR: 26.25 %
Low
87.5
High
307.9
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Piramal Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Piramal Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Piramal Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Piramal Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Piramal Pharma Ltd.?
The current share price of Piramal Pharma Ltd. is ₹ 190.85 as of 23 Oct 2026.
What is the market capitalisation of Piramal Pharma Ltd.?
The market capitalisation of Piramal Pharma Ltd. stands at ₹ 25,322.80 Cr.
What is the PE ratio of Piramal Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Piramal Pharma Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Piramal Pharma Ltd.?
Piramal Pharma Ltd. has a Return on Equity (ROE) of -4.00% and a Return on Capital Employed (ROCE) of 1.87% as per the latest financial reports.
What is the 52-week high and low of Piramal Pharma Ltd.?
The 52-week high of Piramal Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Piramal Pharma Ltd.?
The dividend yield of Piramal Pharma Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Piramal Pharma Ltd.?
Foreign Institutional Investors (FII) hold 13.65%, Domestic Institutional Investors (DII) hold 13.97% and retail/public investors hold 35.49% of Piramal Pharma Ltd. shares.
What sector does Piramal Pharma Ltd. belong to?
Piramal Pharma Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Piramal Pharma Ltd. with a consensus target price of ₹ 232.50, implying 21.82% upside from current levels.
What is the beta of Piramal Pharma Ltd.?
The beta of Piramal Pharma Ltd. is 1.11, indicating its price volatility relative to the broader market. Over the past 1 year, Piramal Pharma Ltd. has delivered an absolute return of -1.38%.
What is the RSI of Piramal Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Piramal Pharma Ltd. is 38.98, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.